HR

Active Director Designated Partner DIN 10030217
DIN 10030217 First appointment Nov 2022 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Nov 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Hem Raj

Data last updated:

Hem Raj is a Designated Partner at Zoemed Pharma Llp (since 2024) and Designated Partner at Sky Hawk Medicare Llp (since 2022). The companies operate in Business Services.

DIN 10030217
Primary Designation Designated Partner
Industry Business Services
First Appointment 24 Nov 2022
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner08 Apr 20242017Active
Designated Partner24 Nov 20222022Active

Board colleagues of Hem Raj

NameDINCompanyDesignation
Hansraj10030218Zoemed Pharma Llp , Sky Hawk Medicare LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Sky Hawk Medicare Llp
Zoemed Pharma Llp
Premium access

Shareholding and investment profile for Hem Raj

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hem Raj

Hem Raj currently holds 2 directorships: Zoemed Pharma Llp (Designated Partner, since 08 Apr 2024); Sky Hawk Medicare Llp (Designated Partner, since 24 Nov 2022).

Hem Raj was first appointed on 24 Nov 2022 as Designated Partner at Sky Hawk Medicare Llp. The most recent appointment on record is 08 Apr 2024 at Zoemed Pharma Llp.

The current boards of Hem Raj's companies include Hansraj (Zoemed Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available